These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26718331)

  • 1. Survivin activates NF‑κB p65 via the IKKβ promoter in esophageal squamous cell carcinoma.
    Zeng W; Li H; Chen Y; Lv H; Liu L; Ran J; Sun X; Bieerkehazhi S; Liu Y; Li X; Lai W; Watibieke J; Dawulietihan M; Li X; Li H
    Mol Med Rep; 2016 Feb; 13(2):1869-80. PubMed ID: 26718331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair.
    Qin Q; Cheng H; Lu J; Zhan L; Zheng J; Cai J; Yang X; Xu L; Zhu H; Zhang C; Liu J; Ma J; Zhang X; Dai S; Sun X
    J Hematol Oncol; 2014 Aug; 7():62. PubMed ID: 25139395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Neddylation Inhibition on Inflammation-Induced MMP9 Gene Expression in Esophageal Squamous Cell Carcinoma.
    Hryniewicz-Jankowska A; Wierzbicki J; Tabola R; Stach K; Sossey-Alaoui K; Augoff K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Mcl-1 by constitutive activation of NF-κB contributes to cell viability in human esophageal squamous cell carcinoma cells.
    Liu H; Yang J; Yuan Y; Xia Z; Chen M; Xie L; Ma X; Wang J; Ouyang S; Wu Q; Yu F; Zhou X; Yang Y; Cao Y; Hu J; Yin B
    BMC Cancer; 2014 Feb; 14():98. PubMed ID: 24529193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
    Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
    Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small interfering RNA targeting NF-κB p65 alone or combined with 5-FU inhibits growth of esophageal squamous cell carcinoma in nude mice.
    Tian F; Fan T; Jiang Y; Zhang X; Wang X
    Pathol Res Pract; 2012 Jan; 208(1):32-8. PubMed ID: 22186294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLK1 Is transcriptionally activated by NF-κB during cell detachment and enhances anoikis resistance through inhibiting β-catenin degradation in esophageal squamous cell carcinoma.
    Lin DC; Zhang Y; Pan QJ; Yang H; Shi ZZ; Xie ZH; Wang BS; Hao JJ; Zhang TT; Xu X; Zhan QM; Wang MR
    Clin Cancer Res; 2011 Jul; 17(13):4285-95. PubMed ID: 21610149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice.
    Zhao N; Mao Y; Han G; Ju Q; Zhou L; Liu F; Xu Y; Zhao X
    Oncotarget; 2015 Jul; 6(21):18445-59. PubMed ID: 26090615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
    Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
    J Biol Chem; 2005 Mar; 280(11):10326-32. PubMed ID: 15611068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner.
    Yeramian A; Santacana M; Sorolla A; Llobet D; Encinas M; Velasco A; Bahi N; Eritja N; Domingo M; Oliva E; Dolcet X; Matias-Guiu X
    Lab Invest; 2011 Jun; 91(6):859-71. PubMed ID: 21537326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JUND facilitates proliferation and angiogenesis of esophageal squamous cell carcinoma cell via MAPRE2 up-regulation.
    Zhang D; Pan G; Cheng N; Sun L; Zhou X; Li C; Zhao J
    Tissue Cell; 2023 Apr; 81():102010. PubMed ID: 36608637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma.
    Peng H; Yao S; Dong Q; Zhang Y; Gong W; Jia Z; Yan L
    Medicine (Baltimore); 2018 Aug; 97(31):e11697. PubMed ID: 30075571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA.
    Tian F; Zang WD; Hou WH; Liu HT; Xue LX
    Acta Biochim Biophys Sin (Shanghai); 2006 May; 38(5):318-26. PubMed ID: 16680372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.
    Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF
    Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.
    Chang E; Donahue J; Smith A; Hornick J; Rao JN; Wang JY; Battafarano RJ
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):225-32. PubMed ID: 20236666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
    Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
    Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.